Quick Answer
Kodiak Sciences Inc. reported Research And Development Expense of $182.37 million for the year ending 2025.
- Kodiak Sciences Inc. showed an increase of +44.6% in Research And Development Expense from 2024 to 2025.
- This data is from Kodiak Sciences Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: $3.1 thousand | Q1 2018: $3.64 million | Q2 2018: $3.59 million | Q3 2018: $4.71 million | Q1 2019: $5.72 million | Q2 2019: $8.84 million | Q3 2019: $10.12 million | Q1 2020: $20.17 million | Q2 2020: $20.56 million | Q3 2020: $29.31 million | Q1 2021: $40.34 million | Q2 2021: $45.40 million | Q3 2021: $56.00 million | Q1 2022: $76.18 million | Q2 2022: $73.74 million | Q3 2022: $61.68 million | Q1 2023: $56.52 million | Q2 2023: $66.96 million | Q3 2023: $36.19 million | Q1 2024: $29.93 million | Q2 2024: $32.51 million | Q3 2024: $31.88 million | Q1 2025: $43.64 million | Q2 2025: $42.76 million | Q3 2025: $50.48 million.
- Over the full 10 years of available data (2016 to 2025), Kodiak Sciences Inc.'s Research And Development Expense has grown by 1,197.8%.
- Historical annual values: Fiscal year 2025: $182.37 million | Fiscal year 2024: $126.10 million | Fiscal year 2023: $206.30 million | Fiscal year 2022: $267.59 million | Fiscal year 2021: $217.34 million | Fiscal year 2020: $107.39 million | Fiscal year 2019: $37.51 million | Fiscal year 2018: $18.79 million | Fiscal year 2017: $22.02 million | Fiscal year 2016: $14.05 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: